Topics

Companies Related to "Effect of Salicylate on Glucose Metabolism in Insulin Resistance States" [Most Relevant Company Matches] RSS

14:57 EDT 2nd April 2020 | BioPortfolio

Here are the most relevant search results for "Effect of Salicylate on Glucose Metabolism in Insulin Resistance States" found in our extensive corporate database of over 50,000 company records.

Showing "Effect Salicylate Glucose Metabolism Insulin Resistance States" Companies 1–25 of 4,100+

Extremely Relevant

Diasome Pharmaceuticals, Inc.

Diasome Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. Based on more than thirty years of research and development in the fields of cell receptor targeting, insulin formulation, and hepatic (liver) glucose metabolism, the companyâ€...


Relevant

Medtronic Diabetes

At Medtronic Diabetes, our 20 plus year history vividly reflects our dedication and ongoing vision to develop an "artificial pancreas". In 1983, we pioneered the idea of continuous insulin delivery, introducing our first insulin pump in an effort to find a "better way" to deliver insulin for people with diabetes. Since that time, Medtronic Diabetes has remained the market leader, earning a reputat...

GOLO, LLC

GOLO is an affordable 3-tier weight management program that helps consumers achieve healthy, sustainable weight loss and help reverse weight related health conditions. GOLO’s team of researchers, doctors and pharmacists found that managing glucose and insulin by not restricting calories or depriving the body of important fats and carbohydrates was a m...


NiliMEDIX

NiliMEDIX develops innovative durable (to be used for several years) and disposable (replaced every 2-3 days) insulin pumps for helping diabetics manage their diabetes.Insulin pumps deliver insulin the way a healthy pancreas does allowing freedom in daily activities and improving the quality of life of their users.Moreover, the pumps usually decrease the needed daily amount of insulin by reducing ...

Medality Medical LLC

Medality Medical LLC, a privately funded (including an NIH grant) medical technology company, is focused on reversing type 2 diabetes and associated obesity. Its patented proprietary technology enables the gentle and selective extraction of excess mesenteric visceral fat, which has been associated with insulin resistance, a precursor to type 2 diabetes. In...

Defymed

Defymed is a spin -off of the “Centre Europeen d’etude du Diabete”  (CeeD) which has been working on the conception of a bio-artificial pancreas since 1996. This work was carried out in tight collaboration with the “Centre de Transfert de Technologie du Mans” (CTTM) and STATICE in the frame of two research European programs: FP4 (1996-2000) and FP6 (2004-2007...

Tandem Diabetes Care®, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump current...

DiabHealthVit-(DHV)

DiabHealthVit-(DHV) is a multivitamin for the improvement of the glucose metabolism and the prevention of cardiovascular disease and neuropathy.

Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump current...

Dance Pharma

Dance is a San Francisco based, global company focused exclusively on creating a line of small, patient friendly, pain-less, low cost insulin inhalers for the world diabetes market. In addition to providing inhaled insulin to those who have become insulin dependent, the company also intends to enable introduction of insulin much earlier in the disease proc...

Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACC...

Metabolex, Inc.

Metabolex is dedicated to the discovery and development of novel therapeutics that will transform the treatment of diabetes and related metabolic disorders. We have created the largest database of genes involved in the disease and have used the information to generate a pipeline of potentially ground-breaking diabetes treatments.Our lead drug candidate, metaglidasen, is a novel, oral insulin sensi...

Nova Biomedical Corporation

Nova Biomedical is a world leader in the development of whole blood analyzers to support the care of home based and hospitalized patients. Based upon innovative biosensor technology, Nova glucose monitors are designed for rapid and accurate measurement of patient glucose levels without coding test strips. Nova Biomedical has pioneered many advances in glucose testing and introduced its first gluc...

Ember Therapeutics, Inc.

Ember Therapeutics is a product-focused company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease. Today’s rising epidemic of obesity and Type 2 diabetes coupled with the lack of innovation in the industry’s metabolic disorder treatment pipeline underscores the need for novel, ...

Waratah Pharmaceuticals

Waratah is a dynamic young biopharmaceutical company founded in April 2000 as a spin-off of RTP Pharma Inc. to develop and commercialize products for its novel, patented therapy – Islet Neogenesis Therapy (I.N.T.™) for the treatment of insulin-dependent diabetes. Diabetes is a disease in which the body does not produce or properly use insulin because of damaged or destroyed insulin producing i...

Ember Therapeutics

Ember Therapeutics is a product-focused company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease. Today’s rising epidemic of obesity and Type 2 diabetes coupled with the lack of innovation in the industry’s metabolic disorder treatment pipeline underscores the need for novel, ...

MannKind

MannKind is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Our lead investigational product candidate, Technosphere® Insulin System, is currently in phase 3 clinical trials in the U.S. and Europe to study its safety and efficacy in the treatment of diabetes. This therapy consists of a propri...

Glooko, Inc.

Glooko provides insights into diabetes by enabling both people with diabetes (PWDs) and their care teams with technology to understand and manage diabetes care. Our self-management mobile app automatically syncs data from devices including blood glucose meters, insulin pumps, CGMs, smart insulin pens and many fitness and activity trackers. The broad variet...

Ardian

Ardian, Inc., headquartered in Palo Alto, California, is a private medical device company developing a novel catheter-based treatment for diseases related to sympathetic hyperactivity, including hypertension, chronic kidney disease, insulin resistance and heart failure. These interdependent disease states represent a significant, escalating global health issue. Ardian is the eighth company created...

Argose Incorporated

ArgoseTM is a medical research and development company whose principal focus is to develop a completely noninvasive glucose monitor for the detection and monitoring of glucose levels in both children and adults.

Glucon Inc.

Glucon is developing glucose monitoring devices for the diabetes market. Glucon devices will provide continuous, accurate, and real-time glucose monitoring, for clinical and personal use. Glucon devices employ a novel Photoacoustic (optical and sound-based) technology protected by several granted and pending patents. The products will be small, light- weight and conveniently wearable personal devi...

Shengtai Pharmaceutical, Inc.

Shengtai Pharmaceutical, Inc. through its wholly owned subsidiary, Shengtai Holding, Inc. (SHI), and the Chinese operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a manufacturer and distributor in china of glucose and starch products as pharmaceutical raw materials, other starch products and other glucose products such as corn meals, food and beverage glucose and dextrin. For ...

Glucose Health, Inc.

Glucose Health, Inc. dietary products engage the large and growing market of consumers aware of the seriousness of Type 2 diabetes and proactively seeking natural blood sugar health solutions. The CDC currently estimates 2 in 5 adults – 86 million Americans – will develop Type 2 diabetes in their lifetime. Glucose Health, Inc. dietary products ar...

Mellitus Health

Founded in 2014 as Insulin Algorithms by Mayer Davidson, MD, Josh Davidson and Michael Margolese, the Los Angeles firm rebranded in 2018 as Mellitus Health, Inc. Its cloud-based insulin titration software works with all insulins and combinations and all 125 dosing regimens, providing precision insulin dosing recommendations to clinicians in just seconds. T...

Integrity Applications, Inc.

Integrity Applications, Inc. is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes. Integrity Applications has developed a non-invasive blood glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with di...


More From BioPortfolio on "Effect of Salicylate on Glucose Metabolism in Insulin Resistance States"

Quick Search

Corporate Database Quicklinks